DYNLL1

Across TCGA pan-cancer cohorts, DYNLL1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DYNLL1 data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher DYNLL1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DYNLL1 expression acts as an unfavorable survival marker.

LUAD, LIHC, and UCEC are the cancer types where DYNLL1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.036	0.768	<.001	15	view →
LIHC	OS	Median	All	0.025	0.777	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DYNLL1–LUAD (DFS)

Open the LUAD breakdown →